aid: 1stbiotherapeutics
name: 1ST Biotherapeutics
description: '1ST Biotherapeutics (1STBIO) is a clinical-stage biopharmaceutical company
  founded in 2016 and headquartered in Gyeonggi-do, South Korea. It discovers and develops
  novel small-molecule therapeutics for areas of significant unmet medical need, with
  programs spanning neurodegenerative disease, immuno-oncology, metabolic disease and
  rare/orphan disease, supported by a genomics-based target discovery capability and an
  R&D network of academic, hospital, CRO and investor partners. The company sells no
  software product and operates no developer program: its public web presence is an
  eight-page corporate and investor site with no API, SDK, developer portal or
  machine-readable contract of any kind.'
image: https://www.1stbio.com/android-chrome-192x192.png
url: https://raw.githubusercontent.com/api-evangelist/1stbiotherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-harvest:
  source: secondary-market
  url: https://equityzen.com/company/1stbiotherapeutics
  status: 200
  note: >-
    Secondary-market venue listing the company was surfaced from. Recorded as harvest
    provenance only — it is NOT the company's Website, which is https://www.1stbio.com/.
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-05'
modified: '2026-09-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Life Sciences
- Healthcare
- Oncology
- Neurodegenerative Disease
- Rare Disease
- South Korea
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/1stbiotherapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/1stbiotherapeutics-llms.txt
- type: Website
  url: https://www.1stbio.com/
- type: PrivacyPolicy
  url: https://www.1stbio.com/privacy-policy/
- type: Support
  url: https://www.1stbio.com/contact-us/
x-enrichment:
  date: '2026-09-05'
  status: minimal
  artifacts_added: 3
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    1ST Biotherapeutics is a clinical-stage drug-discovery company whose entire public web
    presence is an eight-page WordPress marketing and investor site; no api./developer./docs./
    dev./portal. subdomain of 1stbio.com resolves in DNS, every /.well-known/ discovery path
    404s, and the only machine-readable endpoint on the domain is the stock WordPress REST
    API discovery document at /wp-json (namespaces wp/v2, oembed/1.0, yoast/v1, gravityforms/v2)
    — default CMS infrastructure, not a product API the company designed or supports.
  evidence:
  - url: https://www.1stbio.com/
    status: 200
  - url: https://www.1stbio.com/openapi.json
    status: 404
  - url: https://www.1stbio.com/.well-known/agent-card.json
    status: 404
  - url: https://www.1stbio.com/llms.txt
    status: 404
  - url: https://www.1stbio.com/wp-json
    status: 200
  checked: '2026-09-05'